Fresenius SE & Co KGaA FSNUF:OTCPK

*Data is delayed | Exchange | USD
Last | 03/13/24 EDT
27.91UNCH (UNCH)
Volume
865
52 week range
25.77 - 32.43
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close27.91
  • 52 Week High32.43
  • 52 Week High Date07/26/23
  • 52 Week Low25.77
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap15,231.38M
  • Shares Out563.24M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close27.91
  • 52 Week High32.43
  • 52 Week High Date07/26/23
  • 52 Week Low25.77
  • 52 Week Low Date10/27/23
  • Market Cap15,231.38M
  • Shares Out563.24M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)0.83
  • P/E (TTM)33.53
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date05/18/2023
  • Div Amount0.92
  • Split Date-
  • Split Factor-

Latest On Fresenius SE & Co KGaA

 

Content From Our Affiliates

Profile

MORE
Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and...
Gerd Krick
Honorary Chairman of the Supervisory Board
Sara Hennicken
Chief Financial Officer, Member of the Management Board
Address
Else-Kroener Strasse 1
Bad Homburg
61352
Germany